S Altimir Losada

Summary

Country: Spain

Publications

  1. doi request reprint Drug therapy optimization at the end of life
    Alfonso J Cruz-Jentoft
    Servicio de Geriatra, Hospital Universitario Ramn y Cajal, Madrid, Spain
    Drugs Aging 29:511-21. 2012
  2. ncbi request reprint [The recent controversy on the use of neuroleptics in the elderly with dementia]
    A J Cruz Jentoft
    Unidad de Geriatria, Hospital Ramon y Cajal, Madrid
    Rev Clin Esp 205:67-9. 2005
  3. doi request reprint Understanding sarcopenia as a geriatric syndrome
    Alfonso J Cruz-Jentoft
    Servicio de Geriatria, Hospital Universitario Ramon y Cajal, Madrid, Spain
    Curr Opin Clin Nutr Metab Care 13:1-7. 2010
  4. ncbi request reprint Silver paper: the future of health promotion and preventive actions, basic research, and clinical aspects of age-related disease--a report of the European Summit on Age-Related Disease
    Alfonso J Cruz-Jentoft
    Hospital Universitario Ramon y Cajal, 28034 Madrid, Spain
    Aging Clin Exp Res 21:376-85. 2009
  5. pmc Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People
    Alfonso J Cruz-Jentoft
    Hospital Universitario Ramon y Cajal, Madrid, Spain
    Age Ageing 39:412-23. 2010
  6. ncbi request reprint Upper age limits in studies submitted to a research ethics committee
    Alfonso J Cruz-Jentoft
    Servicio de Geriatria, Hospital Universitario Ramon y Cajal, Madrid, Spain
    Aging Clin Exp Res 22:175-8. 2010

Collaborators

Detail Information

Publications6

  1. doi request reprint Drug therapy optimization at the end of life
    Alfonso J Cruz-Jentoft
    Servicio de Geriatra, Hospital Universitario Ramn y Cajal, Madrid, Spain
    Drugs Aging 29:511-21. 2012
    ..Solid evidence is lacking to guide optimal pharmacotherapy in most end-of-life settings, especially in non-cancer diseases and very old patients. Some open questions for research are suggested...
  2. ncbi request reprint [The recent controversy on the use of neuroleptics in the elderly with dementia]
    A J Cruz Jentoft
    Unidad de Geriatria, Hospital Ramon y Cajal, Madrid
    Rev Clin Esp 205:67-9. 2005
  3. doi request reprint Understanding sarcopenia as a geriatric syndrome
    Alfonso J Cruz-Jentoft
    Servicio de Geriatria, Hospital Universitario Ramon y Cajal, Madrid, Spain
    Curr Opin Clin Nutr Metab Care 13:1-7. 2010
    ....
  4. ncbi request reprint Silver paper: the future of health promotion and preventive actions, basic research, and clinical aspects of age-related disease--a report of the European Summit on Age-Related Disease
    Alfonso J Cruz-Jentoft
    Hospital Universitario Ramon y Cajal, 28034 Madrid, Spain
    Aging Clin Exp Res 21:376-85. 2009
    ..Its declared intention is to foster changes in policies which may, in the future, reduce the burden of disease in old age...
  5. pmc Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People
    Alfonso J Cruz-Jentoft
    Hospital Universitario Ramon y Cajal, Madrid, Spain
    Age Ageing 39:412-23. 2010
    ..Once an operational definition of sarcopenia is adopted and included in the mainstream of comprehensive geriatric assessment, the next steps are to define the natural course of sarcopenia and to develop and define effective treatment...
  6. ncbi request reprint Upper age limits in studies submitted to a research ethics committee
    Alfonso J Cruz-Jentoft
    Servicio de Geriatria, Hospital Universitario Ramon y Cajal, Madrid, Spain
    Aging Clin Exp Res 22:175-8. 2010
    ..We examined research protocols submitted to a research ethics committee, to ascertain whether they stipulated unjustified upper age limits, and whether these age limits are changing in time...